INDICATIONS

FDA

NON-FDA APPROVED USES

Treatment of influenza for hospitalized adult and pediatric patients for whom therapy with an IV anti-influenza drug is needed.

Limited data available to support efficacy in complicated influenza, or influenza requiring hospitalization or influenza > 48h duration [4].

Peramivir can be considered for treatment failure occurring with use of currently approved anti-influenza drugs (e.g., oseltamivir and zanamivir) and in patients who are unable to take oral or inhaled anti-viral therapy.